Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Cancer Res. 2015 Sep 1;75(17):3596–3607. doi: 10.1158/0008-5472.CAN-15-0159

Figure 3. Selective targeting of ErbB2 on primary cell lines.

Figure 3

(a) Cell lines were stained using anti-ErBb2 Affibody-biotin and detected using streptavidin-allophycocyanin (APC) (open histograms); cells stained with APC only were used as control (grey filled histograms). (b) The panel of CART cells was stimulated with the indicated cell line for 4hr and the % CART cells expressing CD107a was measured by gating on CD3+ cells.